
The development of more sophisticated testing modalities now permits the identification of coronary artery narrowing in asymptomatic adults. The images obtained in these studies provide potential targets for intervention-based therapy.

The development of more sophisticated testing modalities now permits the identification of coronary artery narrowing in asymptomatic adults. The images obtained in these studies provide potential targets for intervention-based therapy.

Worsening painful ulcers on both legs prompted a 62-year-old woman to seek medical attention. She had a history of rheumatoid arthritis (RA), demonstrated by the markedly deformed interphalangeal joints in her thumbs (A), and scleroderma-polymyositis overlap syndrome.

A 74-year-old woman presented with a refractory pruritic eruption. Four months earlier, she had sought evaluation of a thickened, slightly crusted 6 3 8-cm patch on her right ankle of 2 months' duration. Contact dermatitis with secondary impetigo from scratching was suspected, and a topical corticosteroid and an oral antibiotic were prescribed.

I often drive home key points I make to patients by drawing on the paper cover on the examining table. A graph, a key lab value, an anatomical aid--indeed, any kind of visual aid--is likely to help patients "get" the concept I am trying to explain.
The sharply demarcated, smooth red plaques on this 3-year-old's tongue had been present for several months.

Over the past 20 years, the treatment armamentarium for diabetes has greatly expanded: 8 different classes of non-insulin drugs and 8 different types of insulin are now available. The newer classes of agents include disaccharidase inhibitors, thiazolidinediones, meglitinides, glucagonlike peptide analogs, and dipeptidyl peptidase IV inhibitors.

CHICAGO -- Physicians will be able to report smoking-cessation counseling efforts soon using two new Current Procedural Terminology (CPT) codes that address tobacco use specifically.

SYDNEY, Australia -- Stretching before or after exercise won't spare either elite athletes or weekend warriors from muscle soreness one to three days later, investigators here have found.

PHILADELPHIA -- Ulcerative colitis patients had up to a 50% reduction in colectomy risk at one year when treated with infliximab (Remicade), found pooled results of trials at two doses.

SYDNEY, Australia -- Traditional Chinese remedies may ease painful menstrual cramps better than nonsteroidal anti-inflammatories (NSAIDs) and other drugs, according to a Cochrane systematic review.

NASHVILLE -- Mortality for new hemodialysis patients can be reduced by 41% during the first year of treatment by an intensive case monitoring program, researchers here found.

NEWCASTLE, Australia --Three antifibrinolytic agents each reduced blood loss and red-cell transfusions associated with elective surgery, without an increased risk of thrombosis, according to a literature review.

LIVERPOOL, England -- Amniotomy during a spontaneous birth did not reduce the time of labor or improve the condition of the newborn, according to a systematic review of the literature.

PHILADELPHIA -- The benefits of screening colonoscopy extend to patients 80 and older, according to two studies reported here.

STANFORD, Calif. -- In mid-level coronary artery disease, outcomes are about the same for either angioplasty or bypass graft surgery, found researchers here.

PHILADELPHIA -- Most patients with gastroesophageal reflux disease continue to have reflux, despite twice-daily dosing with a proton pump inhibitor, according to results of a study reported here.

PHILADELPHIA -- The FDA has approved topotecan (Hycamtin) capsules for treatment of relapsed small-cell lung cancer, GlaxoSmithKline has announced.

SAN FRANCISCO -- Acupuncture immediately before surgery may reduce postoperative pain, allowing for lower opioid analgesic doses, researchers said here.

ATLANTA -- Invasive infections of methicillin-resistant Staphylococcus aureus (MRSA) may be more common than suspected, according to the first nationwide surveillance estimates.

ROCKVILLE, Md. -- The FDA said today it has received 30 reports of acute pancreatitis in patients taking exenatide (Byetta) for treatment of type 2 diabetes.